Universal Vision Biotechnology financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
NT$317.76M NT$357.53M NT$336.05M NT$396.94M NT$546.23M NT$522.82M NT$691.60M NT$831.53M NT$767.29M NT$916.31M NT$988.44M NT$1.01B NT$1.07B NT$1.08B NT$1.19B NT$1.42B NT$2.05B NT$2.63B NT$3.49B NT$0.00M NT$0.00M
GM % Gross Margin %
46.36% 40.77% 36.18% 45.08% 42.37% 48.21% 51.45% 52.84% 44.00% 56.41% 55.15% 55.77% 55.08% 54.23% 54.19% 57.58% 61.72% 62.18% 61.24% 0.00% 0.00%
OM Operating Margin
30.92% 28.52% 25.37% 18.34% -7.81% -10.28% 0.20% 4.71% -13.73% 9.79% 9.92% 9.09% 10.60% 11.91% 11.70% 17.41% 29.05% 29.20% 30.94% 0.00% 0.00%
EPS Earnings Per Share
NT$-0.66 NT$1.18 NT$2.80 NT$5.71 NT$7.02 NT$10.02 NT$12.68 NT$0.00
Div. Dividends
NT$0.06 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.90 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$1.80 NT$3.77 NT$4.49 NT$5.43 NT$7.74 NT$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 76.27% 0 0 0 0 0 64.29% 66.02% 63.96% 54.19% 61.04% 0
Sha. Shares
0m 0m 0m 0m 34.67m 34.67m 34.67m 46.08m 66.18m 66.12m 66.12m 66.12m 66.12m 76.12m 76.12m 76.12m 76.12m 76.12m 76.12m 0m 0m
OCF Operating Cash Flow
NT$0.00M NT$0.00M NT$55.09M NT$-2.23M NT$92.94M NT$-26.29M NT$84.19M NT$77.91M NT$-39.28M NT$191.69M NT$221.81M NT$183.54M NT$255.13M NT$236.48M NT$273.07M NT$419.18M NT$827.08M NT$911.77M NT$1.27B NT$0.00M NT$0.00M
FCF Free Cash Flow
NT$0.00M NT$0.00M NT$23.04M NT$-72.80M NT$-17.54M NT$-82.68M NT$-223.06M NT$22.79M NT$-128.22M NT$96.86M NT$28.56M NT$-98.05M NT$83.20M NT$101.77M NT$68.28M NT$183.99M NT$531.93M NT$587.33M NT$792.17M NT$1.11B NT$0.00M
FCFS Free Cash Flow Per Share
NT$0.00 NT$0.00 NT$0.59 NT$-1.81 NT$-0.44 NT$-2.06 NT$-5.02 NT$0.48 NT$-1.95 NT$1.36 NT$0.42 NT$-1.54 NT$1.23 NT$1.38 NT$0.88 NT$2.36 NT$6.94 NT$7.66 NT$9.15 NT$0.00 NT$0.00